Cladribine is an antineoplastic agent used to treat hairy cell leukemia and multiple sclerosis. It works by interfering with DNA synthesis in cancer cells, leading to cell death. Cladribine is typically administered under the supervision of healthcare professionals. Common side effects may include nausea, fatigue, and infections. In summary, Cladribine is essential for treating specific cancers and autoimmune conditions.
Cladribine inhibits DNA synthesis by interfering with ribonucleotide reductase and DNA polymerase, leading to the death of rapidly dividing cancer cells.